Dr Linscott on Urinary Cell-free Tumor DNA to Predict MRD in High-risk NMIBC

Joshua Linscott, MD, discusses using urinary cell-free tumor DNA to predict minimal residual disease in high-risk non-muscle invasive bladder cancer.